Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
What is the value of hiring a financial advisor when you're young? Discover how professional guidance can impact your financial journey.
23,649 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Cardano moves to public testing for a scaling upgrade while ADA slides and a wallet exploit tests user trust, widenin...
Palantir rides a wave of AI-driven demand as shares hover around $113. A fresh forecast calls for meaningful upside o...
Micron Technology stunned investors with an earnings beat and an ultra-high gross margin, suggesting it is riding an ...
SpaceX captured attention with its IPO buzz, but jumping in right away can backfire. This guide explains why waiting ...
Bitmine expanded its Ethereum holdings to 5.7 million ETH, adding 27,084 ETH in the past week. The move comes as mark...
Three dirt-cheap stocks under built below $45 each combine durable cash flow with dividend support, offering ballast ...
Uber's growth engine is accelerating even as the stock trades in the low $70s, with analysts split on how quickly pro...
MicroStrategy announces a sweeping Digital Credit Capital Framework that reshapes how it funds Bitcoin purchases and ...
Meta wants cloud could shake up the cloud market and test Amazon's AWS dominance. This guide breaks down what that co...
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Netflix has fallen sharply, but a trough like this can hide opportunity. This guide breaks down what drove the declin...